International Journal of Pharma Professional’s Research (IJPPR) https://ijppronline.com/index.php/IJPPR <p style="text-align: justify;">International Journal of Pharma Professional’s Research (IJPPR) is a peer reviewed open access journal that publishes manuscripts trimonthly under the umbrella of <strong>P.R.S.Educational Trust</strong>. IJPPR is committed to upgrade the depth of subjects across various disciplines of pharmaceutical education with the ultimate aim of expending and spreading the research knowledge of people involved in the noble profession.</p> <p style="text-align: justify;">The journal deals with all branches of pharmacy, pharmacology ,toxicology, experimental, clinical pharmacology, Pharmacognosy, Behavioral pharmacology, Neuropharmacology, analgesia, Cardiovascular pharmacology, Pulmonary, gastrointestinal, urogenital pharmacology, Endocrine pharmacology, Immuno pharmacology, inflammation, Molecular, cellular pharmacology , history of pharmacy. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field. It is essential that authors prepare their manuscripts according to established specifications. Failure to follow them may result in papers being delayed or rejected. Therefore, contributors are strongly encouraged to read these instructions carefully before preparing a manuscript for submission. The manuscripts should be checked carefully for grammatical errors. All papers are subjected to double blind peer review.</p> en-US info@ijppronline.com (Dr. Akhil Sharma) info@ijppronline.com (Dr. Akhil Sharma) Tue, 30 Apr 2024 11:23:58 +0000 OJS 3.1.2.1 http://blogs.law.harvard.edu/tech/rss 60 The diverse marketed formulations of advanced nano drug carrier vehicles (and CVS) in different biomedical treatments: a complete descriptive review https://ijppronline.com/index.php/IJPPR/article/view/397 The field of pharmaceutical science and drug delivery has seen a remarkable transformation in recent years, marked by the emergence of diverse advanced approaches in the development of Novel Drug Delivery Systems (NDDs) and their associated carriers. Nanocarriers are tiny particles that can be used to deliver drugs to the body. They are typically less than 100 nanometres in diameter, which is about 1,000 times smaller than the width of a human hair. NDDs play a pivotal role in enhancing the therapeutic efficacy, safety, and patient compliance of pharmaceuticals. The research community has increasingly focused on creating novel drug delivery systems to address the limitations of conventional drug administration methods. The diversification of these approaches is notable, reflecting the interdisciplinary nature of pharmaceutical sciences. NDDs can be used to deliver drugs to specific sites in the body, control the rate of drug release, and protect drugs from degradation. Carriers play an important role in NDDs. The main highlights of the review articles in to focus on the diverse nano drug carriers including niosome, liposome, aquasome, nanoparticles (NPs) and phytosomes with their marketed available different products with their specified disease targeting. Rahul Pal, Prachi Pandey, Vinay Kumar Rao Khadam, Dr. Himmat Singh Chawra, Dr. Ravindra Pal Singh Copyright (c) 2024 International Journal of Pharma Professional’s Research (IJPPR) https://ijppronline.com/index.php/IJPPR/article/view/397 Tue, 30 Apr 2024 00:00:00 +0000